Introduction {#s1}
============

Since the initial demonstration that mitochondria take up substantial amounts of cytoplasmic Ca^2+^ ([@bib6]), detailed studies have revealed that this uptake can sculpt the cytoplasmic Ca^2+^ transient ([@bib13]), enhance ATP synthesis ([@bib2]), and trigger cell death ([@bib14]). Of several pathways for Ca^2+^ entry, a uniporter found in the inner membrane possesses the largest capacity for uptake and was shown to be a highly Ca^2+^-selective ion channel ([@bib9]). However, despite this substantial progress, the identities of the genes encoding the functional uniporter were largely unknown until only recently. In the past several years, investigators from several laboratories have identified *mitochondrial calcium uptake 1* (*MICU1*, formerly *Cbara1*) ([@bib11]), mitochondrial calcium uniporter (*MCU*, formerly *Ccdc109a*) ([@bib3]; [@bib5]), and mitochondrial calcium uniporter regulator 1 (*MCUR1*, formerly *Ccdc90a*) ([@bib10]) as potentially integral components of this channel.

These discoveries have spurred an explosion of research into mitochondrial Ca^2+^ transport, yet an outstanding question in this field is which, if any, of these several genes forms the pore subunit of the channel. So far, the discovery of each of these genes occurred via Ca^2+^ imaging assays following RNAi-mediated knockdown. Although extremely useful for screening, this technique is ill-suited for separating modulatory effects from altered expression of the channel-forming subunit itself, and each of these genes was found to inhibit Ca^2+^ uptake via this assay. This difficulty arises because Ca^2+^ imaging measures Ca^2+^ entry, which depends critically on (i) the number of open portals, (ii) the voltage gradient, and (iii) the Ca^2+^ concentration gradient driving flux, and none of these is controlled during imaging experiments. In fact, changes in Ca^2+^ buffers or efflux pathways can alter matrix Ca^2+^, and changes in pH or other divalents can alter indicator fluorescence, without reflecting a true difference in uniporter activity. Rather, the ideal method for assaying electrogenic ion transport is voltage-clamping, which allows precise control of the voltage and concentration gradient and thus accurate measurement of the changes in channel density.

Initial attempts to apply voltage-clamping focused on *MCU*, which possesses two transmembrane domains and highly-conserved acidic residues in a putative pore domain ([@bib3]; [@bib5]; [@bib4]). However, although MCU peptides reconstituted into lipid bilayers showed some activity in single-channel recordings ([@bib5]), these experiments failed to recapitulate the typical single-channel behavior of the uniporter, most importantly its characteristic conductance and long-lasting openings (99% open probability) ([@bib9]). Although such a discrepancy may be explained by the incorporation of the channel into bilayers in the absence of regulatory subunits, lipid bilayer reconstitution is also notorious for false positive findings. Since it detects the activity of single molecules, channel-like behavior can be measured from trace contaminants after even crystallography-grade purification ([@bib1]). Thus, the identity of the pore-forming subunit remains to be definitively established.

To overcome the limitations of single-channel recordings, we chose to voltage-clamp whole mitoplasts (mitochondria stripped of their outer membrane and expanded osmotically to allow access to the inner membrane) ([Figure 1A](#fig1){ref-type="fig"}). This allows electrophysiological interrogation of all the channels assembled in their native milieu in individual mitochondria. Moreover, this technique allows us to express mutated channels and examine mitochondrial Ca^2+^ currents (*I*~*MiCa*~) for altered key features. Using this method, we show here that *MCU* does recapitulate key features of *I*~*MiCa*~, and show that a single point-mutation can generate resistance to pharmacologic inhibition.10.7554/eLife.00704.003Figure 1.*MCU* expression recapitulates *I*~*MiCa*~.(**A**) A HEK-293T cell mitoplast under differential interference contrast (far left), showing a typical figure-eight shape. The lobe bounded only by the mitochondrial inner membrane appears less dense (white arrow) than the lobe also bounded by the outer membrane (black arrow). Matrix-targeted mCherry demonstrates that the inner membrane forms a surface on both lobes (middle left). GFP-tagged mitofusin-1 (an outer membrane GTPase, middle right) reveals the outer membrane partially encapsulating only one lobe. Far right: merged image. (**B**) Western blots demonstrate reduced MCU expression following short-hairpin RNA-mediated knockdown of *MCU* but not *GFP* (control). ATP5B is a loading control. (**C**) Exemplar current traces demonstrate endogenous *I*~*MiCa*~ in control knockdown (black trace), which is largely blocked by 100 nM RuR (red trace). Voltage ramps from −160 to +80 mV for 750 ms were delivered every 6 s from a holding potential of 0 mV. (**D**) Significantly reduced *I*~*MiCa*~ after *MCU* knockdown. (**E**) Summary data, *n* = 6--10 per condition, error bars report SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.00704.003](10.7554/eLife.00704.003)

Results {#s2}
=======

Stable transfection of HEK-293T cells with a short-hairpin RNA targeting *MCU* produced a substantial reduction in the protein when assayed by Western blot ([Figure 1B](#fig1){ref-type="fig"}) or quantitative real-time polymerase chain reaction (17 ± 5% transcripts remaining compared to shGFP). We isolated mitoplasts from these cells using the Kirichok protocol ([@bib7]; [@bib8]; [Figure 1A](#fig1){ref-type="fig"}). As expected from Ca^2+^-imaging experiments ([@bib3]), mitoplasts from control cells showed robust *I*~*MiCa*~ during voltage ramps from −160 mV to +80 mV ([Figure 1C](#fig1){ref-type="fig"}). Because *I*~*MiCa*~ features a half-saturation value (K~0.5~) of 20 mM \[Ca^2+^\]~bath~, we maximized current by recording in a 100 mM Ca^2+^ gluconate bath solution ([@bib9]). Utilizing high external Ca^2+^ allows us to conclude that changes observed after modifying *MCU* expression is due to altered channel levels rather than modulation of K~0.5~, which might be set by accessory subunits. Other critical features of *I*~*MiCa*~ replicated in HEK-293T cells include its strong inward-rectification and high-affinity blockade by ruthenium red (RuR, 87 ± 2% inhibition in 100 nM RuR, [Figure 1C,E](#fig1){ref-type="fig"}).

Compared to the control condition, *I*~*MiCa*~ in mitoplasts from shMCU-expressing cells was markedly smaller ([Figure 1D](#fig1){ref-type="fig"}). The RuR-sensitive component of total Ca^2+^ current was reduced by 78 ± 14% (p\<0.001, [Figure 1E](#fig1){ref-type="fig"}), with no significant difference in the RuR-insensitive residual component, suggesting that the knockdown was specific to *I*~*MiCa*~ and not a generalized reduction in membrane conductance. Moreover, differences were not due to alterations in mitochondrial structure, as mitoplast capacitance, a surrogate for inner membrane surface area (100µm^2^/pF), was consistent across all conditions tested here (shGFP: 0.48 ± 0.10 pF, shMCU: 0.34 ± 0.09 pF, p\>0.05).

Next, we examined if overexpression of wild-type or mutant human MCU proteins substantially changed *I*~*MiCa*~. We focused on an MCU mutated to encode an alanine at a highly-conserved serine in the putative pore-forming loop (S259A) ([@bib3]; [@bib4]). The wild-type and mutant MCU proteins were tagged with a carboxyl-terminal FLAG epitope, and localized appropriately to mitochondria ([Figure 2A,B](#fig2){ref-type="fig"}). To confirm targeting to the inner membrane, we treated HEK-293T mitochondrial fractions with increasing concentrations of digitonin, and assayed for enzymatic digestion with proteinase K ([@bib3]; [Figure 2C,D](#fig2){ref-type="fig"}). Since the FLAG-tagged proteins were protected from digestion to a comparable extent as peptidyl-prolyl cis-trans isomerase F (PPIF, a matrix protein), whereas proteins of the outer- and inter-membrane spaces were not, the MCU constructs are appropriately targeted with their carboxyl-termini facing the mitochondrial matrix. Turning to our whole-mitoplast recordings ([Figure 2E,G](#fig2){ref-type="fig"}), we found that overexpression of wild-type MCU-Flag produced a robust increase in *I*~*MiCa*~ of approximately 3.4-fold compared to endogenous HEK-293T currents (compare to [Figure 1C,E](#fig1){ref-type="fig"}). This enhanced *I*~*MiCa*~ retained its sensitivity to RuR ([Figure 2E,G](#fig2){ref-type="fig"}).10.7554/eLife.00704.004Figure 2.*MCU* mutants alter *I*~*MiCa*~ sensitivity to RuR.(**A**) Confocal imaging of HEK-293T cells for FLAG-tagged MCU (left) and cytochrome C oxidase I (a mitochondrial marker, center). The merged image (right) shows colocalization. (**B**) As in (**A**) but for MCU-259A-FLAG. (**C**) Immunoblot analysis of proteinase K digestion after wild-type MCU-FLAG-expressing HEK-293T mitochondrial fractions are digitonin-permeabilized at the specified concentrations, confirming mitochondrial targeting. (**D**) Proteinase K digestion analysis for MCU-S259A-FLAG mutant. (**E**) Significant increase in *I*~*MiCa*~ after MCU-FLAG overexpression. (**F**) Loss of RuR block in S259A mutant. (**G**) Summary data, *n* = 5--9 per condition.**DOI:** [http://dx.doi.org/10.7554/eLife.00704.004](10.7554/eLife.00704.004)

Finally, we studied the S259A-MCU mutant to see if it disrupted key features of *I*~*MiCa*~. In Ca^2+^-imaging experiments, this mutant had preserved Ca^2+^ uptake but diminished sensitivity to uniporter inhibitors ([@bib3]). At baseline, mitoplasts from HEK-293T cells transfected with the S259A mutant had capacitances similar to mitoplasts after wild-type MCU overexpression (MCU-Flag: 0.32 ± 0.06 pF, S259A: 0.29 ± 0.10 pF, p\>0.05). Moreover, S259A overexpression mirrored the increase in *I*~*MiCa*~ seen after wild-type MCU transfection, confirming a fully-functional channel ([Figure 2F,G](#fig2){ref-type="fig"}). However, this variant displayed markedly decreased sensitivity to RuR, with minimal inhibition at 100 nM. Since overexpression occurred on a background of endogenous channels, this mutant appears to act in a dominant-negative fashion. In particular, the S295A RuR-inhibited fraction (148 ± 33 pA/pF, [Figure 2G](#fig2){ref-type="fig"}) was much less than the RuR-inhibited fraction in endogenous *I*~*MiCa*~ (372 ± 42 pA/pF, [Figure 1F](#fig1){ref-type="fig"}). This suggests that, since the channel is an oligomer of multiple MCU subunits ([@bib3]), mutant S259A-MCU can incorporate with endogenous, wild-type subunits to form a Ca^2+^-conducting channel, which nonetheless has drastically-reduced RuR sensitivity.

Discussion {#s3}
==========

In our study, we use the most direct assay available to measure mitochondrial Ca^2+^ currents---whole-mitoplast electrophysiology ([@bib9]). By isolating mitoplasts and recording directly from all the channels embedded in the inner membrane, we measure the ensemble current and thus avoid confounding minor contaminants. This method, moreover, is the same technique that originally demonstrated that the mitochondrial Ca^2+^ uniporter was an ion channel, allowing us to make a direct comparison to the characteristic features of this current (*I*~*MiCa*~), and to determine if the genetically-modified channels could alter them.

We focused on MCU, the leading candidate for the pore-forming subunit, as it possesses two transmembrane domains and has highly-conserved acidic residues in a putative pore-like domain. First, we show that reducing *MCU* transcripts via knockdown, or enhancing them through overexpression, produce parallel changes in *I*~*MiCa*~. Second, we show that a central feature of *I*~*MiCa*~---its exquisite sensitivity to blockade with ruthenium red---can be abolished via a single point mutation in the pore domain. MCU subunits carrying this mutation act in a dominant-negative fashion, producing functional channels that conduct Ca^2+^ ions but are largely insensitive to ruthenium red. We conclude that the functional uniporter pore at the mitochondrial inner membrane is formed by MCU multimers. We believe these experiments put to rest the outstanding question of the pore identity, firmly establishing that *MCU* produces *I*~*MiCa*~.

Materials and methods {#s4}
=====================

Cell culture {#s4-1}
------------

HEK-293T were obtained from ATCC and grown in Dulbecco's modified Eagle medium with high glucose supplemented with 10% fetal bovine serum and penicillin/streptomycin (Life Technologies, Grand Island, NY). HEK-293T cells (250,000 cells per well) were infected with lentivirus expressing short hairpin RNA (for knockdown experiments) or wild-type or mutant FLAG-tagged *MCU*. 2 days after infection, cells were split and selected with the appropriate antibiotic. Stable HEK-293T cells lines expressing shGFP and shMCU were maintained in 2 μg/ml puromycin (Sigma, St. Louis, MO), while MCU-FLAG and S259A lines were maintained in 200 μg/ml hygromycin B (Sigma).

Plasmids {#s4-2}
--------

Vectors for expressing shRNA (pLKO.1) were obtained from the Broad Institute's RNAi Consortium (Sigma). To silence *MCU*, we used a hairpin targeting the 3′ UTR, with sequence 5′-GCAAGGAGTTTCTTTCTCTTT-3′ (TRCN0000133861). The control hairpin was against GFP, with sequence 5′-ACAACAGCCACAACGTCTATA-3′ (shGFP) (TRCN0000072181). The FLAG-tagged full-length human *MCU* cDNA (NM_138357.1) was cloned into the pLJM5 vector ([@bib12]). The *MCU* mutant S259A was generated with QuikChange according to the manufacturer's instructions (Agilent, Santa Clara, CA). Human Mitofusin-1 (NM_033540) was cloned out of HEK-293T cell cDNA (see Quantitative polymerase chain reaction section, below) and ligated in-frame into the pEGFP-N3 vector (Clontech, Mountain View, CA) using KpnI and BamHI restriction sites. Matrix-targeted mCherry was engineered by replacing the GFP construct of the pAcGFP1-Mito plasmid (Clontech), using BamHI and NotI restriction sites.

Quantitative polymerase chain reaction {#s4-3}
--------------------------------------

Primers against human *MCU* were designed using PRIMER-Blast (NCBI). The forward primer was 5′-TTCCTGGGACATCATGGAGC-3′, and the reverse primer was 5′-TGTCTGTCTCTGGCTTCTGG-3′. For qPCR, confluent HEK-293T cells were resuspended in TriZOL reagent (Life Technologies), and total RNA was subsequently purified following the manufacturer's instructions. 2 μg of RNA was used to synthesize cDNA using SuperScript ViLo (Life Technologies) and 100 ng of this was used per well for qPCR. Reactions were run in triplicate using SYBR Green (Agilent) on an Eppendorf Mastercycler epgradient S Realplex4 qRT-PCR cycler (Eppendorf, Hauppauge, NY). Analysis compared expression in shMCU cells to shGFP cells using the 2^−ΔΔCt^ method, normalizing to *glyceraldehyde 3-phosphate dehydrogenase* expression.

Western blots {#s4-4}
-------------

10 μg of protein from cell lysates or 5 μg of protein from crude mitochondrial preparations were loaded on 12% or 18% Tris-Glycine gels, proteins were transferred to PVDF membranes and then incubated with the indicated antibodies at 4°C overnight. We used antibodies against TOMM20 (sc-17764; Santa Cruz Biotechnology, Dallas, TX), TIMM23 (No. 611222; BD Biosciences, San Jose, CA), PPIF (ab110324; Abcam, Cambridge, MA), ATP5B (ab14730; Abcam), FLAG epitope (No. 2368; Cell Signaling Technology, Danvers, MA), and MCU (polyclonal chicken antibody raised against residues 41--351 of human MCU tagged with a 6His epitope; Covance, Dedham, MA).

Proteinase K protection assay {#s4-5}
-----------------------------

Two confluent plates of HEK-293T cells were washed with PBS and the cells scraped into 1.5-ml microcentrifuge tubes in 1 ml of final volume. The cells were lysed by passaging through a 27.5 G needle several times. Samples were spun at 800*g* for 10 min at 4°C to pellet nuclei and non-lysed cells. The supernatant was removed and spun separately at 8000*g* for 10 min at 4°C to pellet the mitochondrial fraction. Mitochondria were resuspended in a sucrose buffer (200 mM sucrose, 10 mM Tris-MOPS, 1 mM EGTA-Tris) to a final concentration of 1 mg/ml. 20 μg of mitochondria were treated with digitonin (0.01--0.4%, Sigma) or 1% Triton-X100 (Sigma) and 100 μg/ml of proteinase K for 15 min at room temperature, in a 30 μl final volume. Proteinase K was then inhibited by addition of 5 mM PMSF. 5 μg of protein was loaded to Tris-glycine gels for Western blotting.

Imaging {#s4-6}
-------

Stably-transfected HEK-293T cells were washed in PBS, which was used as the base solution in all following steps. Cell were fixed in 4% formaldehyde, permeabilized in 0.5% Triton-X100, and blocked in 10% goat serum, 0.1% Tween-20 (Biorad, Hercules, CA). Primary antibodies were a rabbit anti-FLAG and a mouse anti-MTCO1 (a mitochondrial marker, ab14705; Abcam). Secondary antibodies were Alexa-488 conjugated to a goat anti-rabbit, and Alexa-546 conjugated to goat anti-mouse (Life Technologies). Cells were imaged on an Olympus Fluoview 1000 confocal microscope (Center Valley, PA).

For mitoplast images, HEK-293T cells were co-transfected with mt-mCherry and MFN1-GFP plasmids using Lipofectamine 2000 reagent (Life Technologies) according to the manufacturer's instructions. Mitoplasts were isolated (as described in 'Whole-mitoplast recording') 2 days following transfection, and imaged on the confocal microscope as above.

Brightness levels have been slightly adjusted in the images to improve contrast. This adjustment has been applied to each image as a whole and has not obscured or eliminated any particular feature of the image. All reagents were from Sigma unless otherwise stated.

Whole-mitoplast recording {#s4-7}
-------------------------

We adapted prior methods to HEK-293T cells ([@bib7]; [@bib8]). Cells were grown to confluency on three 15-cm dishes. All subsequent manipulations were done using ice-cold solutions and equipment. Cells were scraped onto divalent-free PBS and spun down to pellet cells. The cell pellet was subsequently resuspended in a sucrose solution (250 mM sucrose, 5 mM HEPES, 1 mM EGTA, 0.1% BSA). The suspension was homogenized using an overhead stirrer. Centrifugation at 700*g* pelleted nuclei. The supernatant was transferred to a new tube and centrifuged at 8500*g* to pellet a crude mitochondrial fraction. This pellet was resuspended in a hypertonic mannitol solution (440 mM mannitol, 140 mM sucrose, 5 mM HEPES, 1 mM EGTA) for 10 min. The suspension was then passed through a French Pressure Cell homogenizer (Thermo Scientific, Waltham, MA) at 2000 p.s.i. to disrupt the mitochondrial outer membrane. The eluate was centrifuged at 10,500*g* to pellet mitoplasts. Mitoplasts were stored in a hypertonic solution (750 mM KCl, 100 mM HEPES, 1 mM EGTA) on ice and protected from light.

For recordings, mitoplasts were aliquoted into the initial bath solution (150 mM KCl, 10 mM HEPES, 1 mM EGTA) to allow them to expand for 20 min. An individual mitoplast was visualized and attached to the pipette tip with gentle suction. Pipettes were formed from borosilicate glass (Sutter, Novato, CA) with tip resistances of 20--60 MOhm. We used sodium gluconate for pipette internal solutions (150 mM sodium gluconate, 10 mM HEPES, 2 mM EDTA, with sucrose to achieve an osmolarity of 410--430 mOsmol). Electrophysiology was performed using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA). Upon giga-ohm seal formation, pipette capacitance transients were cancelled, and the inner membrane was ruptured by 10--50 ms pulses (350--1000 mV). After establishing the whole-mitoplast configuration, a series of 4 ms pulses of 20 mV were recorded to allow curve fitting for capacitance measurements. Bath solutions were subsequently exchanged for a high-Ca^2+^ solution (100 mM calcium gluconate, 20 mM HEPES, 2 mM CaCl~2~, with sucrose to achieve osmolarity of 295--305 mOsms) and high-Ca^2+^ +100 nM RuR solution (Sigma). RuR solutions were prepared fresh for every experiment. Solution exchanges were rapid, as prolonged matrix exposures to Ca^2+^ caused activation of a significant leak component. Comparisons were made via the Student's *t-*test.
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Thank you for sending your work entitled "*MCU* encodes the pore conducting mitochondrial calcium currents" for consideration at *eLife*. Your article has been favorably evaluated by a Senior editor and 3 reviewers, one of whom is a member of our Board of Reviewing Editors.

The following individuals responsible for the peer review of your submission want to reveal their identity: Richard Aldrich (Reviewing editor); Jon Lederer (peer reviewer).

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

This work for the first time addresses structure-function relationships within the mitochondrial Ca^2+^ uniporter using the patch--clamp technique. Although indirect optical methods helped to identify three candidate proteins important for the activity of the mitochondrial Ca^2+^ uniporter (*MICU1*, *MCU*, and *MCUR1*), the subsequent attempts to understand the exact functions of these proteins led to little progress and produced controversial results. In this manuscript, the authors provide strong evidence that one of the candidate proteins, MCU, forms the pore of the mitochondrial Ca^2+^ uniporter. Since this is the first structure--function study of the *MCU* using the patch--clamp technique, methodologically this works sets an important precedent in the field.

Overall, the manuscript is well written and provides sufficient evidence to suggest that the MCU protein is a pore-forming subunit of the mitochondrial Ca^2+^ uniporter. There are two important points to be addressed:

1\) The quality of the image of an 8-shaped mitoplast on [Figure 1A](#fig1){ref-type="fig"} is rather low. From this image it is not clear whether this is a real 8-shaped mitoplast or two attached swollen round-shaped mitoplasts. Also, in addition to the mitoplast(s), the DIC image contains debris that complicates our understanding. It would be useful to provide an image of higher quality.

2\) [Figure 1D,E](#fig1){ref-type="fig"} and [Figure 2E,F](#fig2){ref-type="fig"}: It is important to describe in the main text or in the figure legends how these traces were obtained. Are these responses to a voltage ramp protocol? What was the exact voltage protocol used? If a ramp protocol was used, it would perhaps be somewhat misleading to say that these traces are real I/V curves (as in the legend to [Figure 1](#fig1){ref-type="fig"}).
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Author response

*1) The quality of the image of an 8-shaped mitoplast on [Figure 1A](#fig1){ref-type="fig"} is rather low. From this image it is not clear whether this is a real 8-shaped mitoplast or two attached swollen round-shaped mitoplasts. Also, in addition to the mitoplast(s), the DIC image contains debris that complicates our understanding. It would be useful to provide an image of higher quality*.

We have replaced the mitoplast image from [Figure 1](#fig1){ref-type="fig"} with the new one shown below.

For this image, we co-transfected HEK cells with a plasmid encoding a mitochondrial matrix-targeted mCherry fluorescent protein, as well as a plasmid encoding GFP-tagged mitofusin-1, a mitochondrial outer membrane GTPase. This image is free of debris, and demonstrates that the structure is one mitoplast. We have replaced the figure legend as follows:

"A HEK-293T cell mitoplast under differential interference contrast (far left), showing a typical figure-eight shape. The lobe bounded only by the mitochondrial inner membrane appears less dense (white arrow) than the lobe also bounded by the outer membrane (black arrow). Matrix-targeted mCherry demonstrates that the inner membrane forms a surface on both lobes (middle left). GFP-tagged mitofusin-1 (an outer membrane GTPase, middle right) reveals the outer membrane partially encapsulating only one lobe. Far right: merged image."

*2) [Figure 1D,E](#fig1){ref-type="fig"} and [Figure 2E,F](#fig2){ref-type="fig"}: It is important to describe in the main text or in the figure legends how these traces were obtained. Are these responses to a voltage ramp protocol? What was the exact voltage protocol used? If a ramp protocol was used, it would perhaps be somewhat misleading to say that these traces are real I/V curves (as in the legend to [Figure 1](#fig1){ref-type="fig"})*.

We have taken out the mention of I/V curves, and added the following to the figure legend to describe the voltage command protocol:

"Voltage ramps from −160 to +80 mV for 750 ms were delivered every 6 seconds from a holding potential of 0 mV."
